Alkeus : Developing treatments for blindness, in particular dry-AMD and Stargardt disease.
Alkeus is a clinical stage biopharmaceutical start-up

» dry-AMD

The most common form of unpreventable blindness, dry-AMD affects the vision of millions of Americans. Click here to learn more about dry-AMD and Alkeus future trials.

» Stargardt Disease

A rare genetic disease, Stargardt disease is a major cause of blindness in children and is currently untreatable and irreversible. Click this box to stay informed of Alkeus upcoming clinical trials.

» Our Science

Alkeus drug candidates result from years of research by leading ophthalmic scientists. Click here to learn more about vision, our scientific approach and our preclinical animal data.

» About Us

Our team is experienced and dedicated to developing treatments for blindness. We collaborate heavily with leading physicians worldwide. Click here to learn more about Alkeus.